Pandox: Pandox completes legal separation of Dalata and previously announced divestment of hotel operations business to Scandic

By Modular Finance

Pandox AB (publ) (“Pandox”) has today completed the sale of the hotel operations business of the Dalata Hotel Group (“Dalata”) to Scandic Hotels Group AB (“Scandic”).

The purchase price is based on an underlying enterprise value of MEUR 500, and the proceeds have been used in full to repay financing provided by DNB Bank ASA, which has been reported in the balance sheet as Liabilities related to assets held for sale. Final cash consideration is subject to customary adjustments for cash, debt and working capital.

MEUR 665 of the acquisition facility remains. Pandox intends to refinance this facility as soon as possible.

Following the divestment of Dalata’s hotel operations business, Pandox retains Dalata’s hotel property business, made up of 32 hotel properties in Ireland and the UK, with new 30-year revenue-based lease agreements with minimum-guaranteed rent levels with Scandic.

“The acquisition of Dalata is a historic milestone for Pandox and demonstrates our ability to execute complex, value-creating transactions in an international environment. Through the transaction, we have added a significant business in Ireland and the UK to our portfolio made up of 32 hotel properties, with profitable, long-term revenue-based lease agreements. We have already created significant value through the transaction and now look forward to successfully managing a high-quality hotel property portfolio in two attractive hotel markets,” says Liia Nõu, CEO of Pandox.

As of 30 September 2026, Pandox’s weighted average unexpired lease term (WAULT), including the lease agreements with Scandic for the Dalata properties, was 17.1 years.

For further information, please refer to the press releases dated 15 July 2025 and 10 November 2025.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.